share_log

九强生物:中国国际金融股份有限公司关于北京九强生物技术股份有限公司对国药集团财务有限公司2023年度风险持续评估报告的核查意见

Jiuqiang Biotech: Opinions of China International Finance Corporation on Beijing Jiuqiang Biotechnology Co., Ltd.\'s 2023 Continued Risk Assessment Report of Sinopharm Group Finance Co., Ltd.

SZSI ·  Mar 29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more